Mitchell, Malcolm I

Tadalafil pharmacokinetics in healthy subjects

Forgue, S. T., Patterson, B. E., Bedding, A. W., Payne, C. D., Phillips, D. L., Wrishko, R. E., & Mitchell, M. I. (2006) · British Journal of Clinical Pharmacology

Sexual function and dysfunction studiesPharmacogenetics and Drug Metabolism

Cited by 284

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

McDonnell, D. P., Detke, H. C., Bergstrom, R. F., Kothare, P., Johnson, J., Stickelmeyer, M., Sanchez-Felix, M. V., Sorsaburu, S., & Mitchell, M. I. (2010) · BMC Psychiatry

Schizophrenia research and treatmentIntramuscular injections and effects

Cited by 96

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial

Kothare, P. A., Seger, M. E., Northrup, J., Mace, K., Mitchell, M. I., & Linnebjerg, H. (2012) · BMC Clinical Pharmacology

Pharmacogenetics and Drug MetabolismReproductive Health and Contraception

Cited by 35

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Mitchell, M., Kothare, P., Bergstrom, R., Zhao, F., Jen, K. Y., Walker, D., Johnson, J., & McDonnell, D. (2013) · Clinical Therapeutics

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 31